IV iron
Ferric carboxymaltose
Brand names: Ferinject
Adult dose
Dose: Total replacement dose calculated by Hb and weight; max 1000mg per session over 15 min, max 20mg/kg
Route: IV infusion
Frequency: per dose
Clinical pearls
- Rapid IV iron replacement
- MHRA: hypophosphataemia may be prolonged — check phosphate before re-dosing
Contraindications
- 1st trimester pregnancy
- Iron overload
- Anaemia not due to iron deficiency
- History of severe hypersensitivity to IV iron
Side effects
- Hypersensitivity (incl. anaphylaxis)
- Hypophosphataemia (especially with repeated doses)
- Headache
- Hypotension
- Skin staining at extravasation
Interactions
- Oral iron (separate by ≥5 days post-IV)
Monitoring
- Ferritin
- TSAT
- Hb
- Phosphate (if symptomatic or repeat doses)
Reference: BNF; NICE NG8; MHRA Drug Safety Update; https://bnf.nice.org.uk/drugs/ferric-carboxymaltose/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO